Purchase Order 75F40119P10573
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lonza Walkersville, Inc. for the delivery of Nucleofector units, a specialized piece of laboratory equipment used for transfecting cells. The $13,022 contract was awarded on November 6, 2013 with a completion date of November 7, 2013. The award was not set aside for any specific business type. Lonza Walkersville, Inc....
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Lonza Walkersville, Inc., a subsidiary of Lonza Group Ltd. The $12,251.00 contract is for the delivery of a 4D Nucleofector Transfection System, a specialized laboratory equipment used for cell transfection in biomedical research. The contract does not have a set-aside designation. Lonza Walkersville is a...
- Lonza Walkersville, Inc. was awarded a firm fixed price Blanket Purchase Agreement (BPA) call valued at $15.1K by the Department of Health and Human Services (HHS) Office of Logistics and Acquisition Operations for one AAF-1002B 4D Nucleofector Core Unit FL1 instrument. The award was issued on August 15, 2014, with a completion date of December 31, 2014, and will be performed in Bethesda, Maryland. This contract represents an open competition award with no set-aside designation and is a task...
- This is a firm fixed-price purchase order valued at $9,947.51, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc. for Nucleofector laboratory equipment. The contract has a completion date of September 5, 2014 and was awarded on August 27, 2014. Lonza Walkersville is a subsidiary of Lonza Group Ltd., a global life sciences company, and is a leading provider of specialized biological...
- This is a firm-fixed-price contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to Lonza Walkersville, Inc. The $24,220.01 contract is for the delivery of 4D Nucleofector Core UNI equipment and related products. Lonza Walkersville is a for-profit manufacturer and supplier of specialized biological materials, laboratory equipment, and scientific services. This award is not set-aside and is a call against an existing Blanket Purchase...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lonza Walkersville, Inc., a subsidiary of Lonza Group Ltd. The $36,600 firm fixed-price purchase order is for the delivery of a 4D-Nucleofector X-Unit, a specialized laboratory instrument used for cell transfection research. The contract does not have a set-aside designation. Lonza Walkersville is a leading provider of...
- This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc., a foreign-owned for-profit manufacturer of laboratory equipment and scientific supplies. The $22,703.01 contract is for the provision of a Lonza 4D Nucleofector transfection instrument and associated component parts to support genome engineering research using CRISPR-Cas9 technology, particularly...
- The National Institute of Allergy and Infectious Diseases awarded a $18,929.24 firm fixed-price purchase order to Lonza Walkersville, Inc. for Nucleofector core units with extended warranty and unit guarantee. The contract was awarded on September 22, 2021, with an ultimate completion date of October 25, 2021, and utilized no set-aside designation, indicating open competition. Performance of this contract is based in Germany. This procurement represents a single task order against Lonza...
- This federal contract award, with an ID of 12305B21P0230, was issued by the Northeast Area of a civilian federal agency to Lonza Walkersville, Inc., a foreign-owned, for-profit manufacturer of biological materials, laboratory equipment, and scientific services. The $19,129.24 firm fixed-price purchase order is for the supply of "4D NUCLEOFECTOR FROM LONZA", a specialized transfection device. The award is not associated with a set-aside program. Lonza Walkersville has a significant...
- The National Cancer Institute awarded a $19,287.85 firm fixed-price purchase order to Lonza Walkersville, Inc. for a 4D-Nucleofector Core Unit and X Unit. The contract, awarded on March 31, 2026, with an ultimate completion date of March 30, 2027, represents a direct procurement with no set-aside designation, indicating open competition. Lonza Walkersville, a foreign-owned, for-profit manufacturer specializing in biological materials and advanced scientific instrumentation, will perform the work...
The Food and Drug Administration awarded a firm fixed price purchase order to Lonza Walkersville, Inc. for the purchase of a 4D Nucleofector instrument and accessories, with a contract ceiling value of $59,695.40. The solicitation was posted on August 19, 2019, with a due date of August 26, 2019, and the contract was awarded on August 29, 2019, with an ultimate completion date of September 3, 2024. This procurement was conducted as open competition with no set-aside designation. The work will be performed in Laurel, Maryland. Lonza Walkersville, Inc., a Maryland-based subsidiary of the global Lonza Group, is a manufacturer of biological materials and laboratory equipment specializing in cell culture and transfection technologies for federal research institutions. The 4D Nucleofector system is an advanced electroporation device widely used in biomedical research for cell engineering and genetic modification applications. This contract modification was executed to de-obligate funds and close out the purchase order, reflecting completion of the procurement action initiated nearly five years prior to final closeout.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Purchase Brand Name Or Equal 4D-Nucleofector instrument | FDA-RFQ-1204596-FO | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 8/19/19, 2:12 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Close Out | ($7k) | 11/14/25 | |
| P00005 | Exercise an Option | $3.6k | 5/2/23 | |
| P00004 | Exercise an Option | $3.6k | 6/29/22 | |
| P00003 | Other Administrative Action | $0 | 3/22/22 | |
| P00002 | Exercise an Option | $3.6k | 4/20/21 |